Direct imaging of RNA loaded lipid-nanoparticles’ self assembly and cellular expression for cancer immunotherapy and RNA-based vaccines
Direct imaging of RNA loaded lipid-nanoparticles’ self assembly and cellular expression for cancer immunotherapy and RNA-based vaccines
复制标题
用于癌症免疫治疗和基于 RNA 的疫苗的 RNA 负载脂质纳米颗粒的自组装和细胞表达的直接成像
DOI:
10.1016/j.bpj.2021.11.2866
复制
发表时间:
2022-02-11
影响因子:
3.4
通讯作者:
Guan J
中科院分区:
文献类型:
--
作者:
Ashbrook J;Chung MC;Mendez-Gomez H;Sayour E;Guan J
The field of immunology has seen a rapid expansion in new cancer immunotherapy and RNA-based vaccines. RNA-based vaccines have recently demonstrated great promise in addressing public health crises such as COVID-19. Additionally, RNA nanoparticle (RNA-NP) technology may be used to create a viable cancer treatment option. RNA-NPs were made by adding RNAs to liposomes which act as a delivery vehicle to safely transport RNA to the body’s immune cells in an attempt to elicit an immune response. However, the understanding of RNA-NP assembly processes and how they relate to downstream immunogenicity is still limited, hindering progress on improving the efficacy of cancer immunotherapy. Advanced imaging with high spatiotemporal resolution is needed to understand how RNA-NPs assemble, how cells interact with RNA-NPs, and which biophysical properties affect transfection efficiency. Here, we manipulate various RNA-NP preparation parameters, such as temperature and concentration, while observing the effect on nanoparticle aggregation using a home-built epifluorescent microscope. Live cell experiments were conducted to determine the downstream effects of these manipulations through RNA-NP uptake as well as transfection efficiency. Our results show that the temperature at which RNA-NPs are incubated greatly affects aggregate area. They also suggest that smaller nanoparticle aggregates are more effective in transfection of DC2. 4 (the mouse dendritic cell line used through the experiment). Our work offers insight into the RNA-NP assembly process and opens up new opportunities to fine-tune the biophysical properties of RNA-NPs to improve cancer immunotherapy.